Optimum visibility
iVolution pro has 2 markers delimiting the stent and 1 tungsten marker in the retractable sheath, indicating the implantation level.
Home
Applications
Endovascular
Peripheral
iVolution pro Self-expanding peripheral stent system
Peripheral
- GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface
- GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis
- GORE® VIATORR® TIPS Endoprosthesis
- Luminor Paclitaxel eluting PTA balloon dilatation catheter
- iVolution pro Self-expanding peripheral stent system
- Sergeant supporting catheter
- Oceanus PTA Peripheral Balloon
- CO2 Injector
iVolution pro Self-expanding peripheral stent system
- GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface
- GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis
- GORE® VIATORR® TIPS Endoprosthesis
- Luminor Paclitaxel eluting PTA balloon dilatation catheter
- iVolution pro Self-expanding peripheral stent system
- Sergeant supporting catheter
- Oceanus PTA Peripheral Balloon
- CO2 Injector
iVolution pro Self-expanding peripheral stent system
PRODUCT FEATURES
Controlled and easy deployment
User-friendly stent thanks to its triple sheath design and ergonomic small handle. The deployment speed is modulated through the handle’s wheel.
Flexible and resistant stent design
The stress is homogeneously distributed to avoid stent fracture. iVolution pro open cell design offers the highest flexibility.
CLINICAL SUPPORT
iVolution pro has demonstrated its safety and efficacy in the following clinical trials
EVOLUTION Trial
Prospective, multicenter trial in femoropopliteal TASC A&B lesions.
88.0% fTLR
at 1 year
TINTIN Trial
Prospective, multicenter trial, with Luminor and iVolution pro combined therapy in long and complex TASC C&D lesions.
62.5% fTLR
at 5 years
Registry iVolution pro in flexion
Observational, multicenter registry in flexion zone.
81.7% fTLR
at 2 years